Philippe Lehert

12.3k total citations · 1 hit paper
172 papers, 7.7k citations indexed

About

Philippe Lehert is a scholar working on Endocrinology, Diabetes and Metabolism, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, Philippe Lehert has authored 172 papers receiving a total of 7.7k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Endocrinology, Diabetes and Metabolism, 35 papers in Public Health, Environmental and Occupational Health and 29 papers in Epidemiology. Recurrent topics in Philippe Lehert's work include Menopause: Health Impacts and Treatments (23 papers), Substance Abuse Treatment and Outcomes (19 papers) and Menstrual Health and Disorders (16 papers). Philippe Lehert is often cited by papers focused on Menopause: Health Impacts and Treatments (23 papers), Substance Abuse Treatment and Outcomes (19 papers) and Menstrual Health and Disorders (16 papers). Philippe Lehert collaborates with scholars based in Belgium, Australia and France. Philippe Lehert's co-authors include Lorraine Dennerstein, Henry Burger, Janet R. Guthrie, Coen D.A. Stehouwer, Adriaan Kooy, M. G. Wulffelé, D. Bets, Marsha Y. Morgan, B.J. Oddens and A. J. M. Donker and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Philippe Lehert

170 papers receiving 7.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial

2010 463 citations J. de Jager, Adriaan Kooy et al. BMJ profile →

Peers

Countries citing papers authored by Philippe Lehert

Since Specialization

Citations

This map shows the geographic impact of Philippe Lehert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Lehert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Lehert more than expected).

Fields of papers citing papers by Philippe Lehert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Lehert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Lehert. The network helps show where Philippe Lehert may publish in the future.

Co-authorship network of co-authors of Philippe Lehert

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Lehert. A scholar is included among the top collaborators of Philippe Lehert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Lehert. Philippe Lehert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Long-Term Efficacy and Safety of Pitolisant for Residual Sleepiness Due to OSA 2023 ·CHEST Journal ·Jean‐Louis Pépin, Valérie Attali, (unknown), Johan Verbraecken, Jan Hedner, Isabelle Lecomte, Renaud Tamisier, Patrick Lévy, Philippe Lehert, Yves Dauvilliers	10
2	The beneficial effect of prophylactic hydrocortisone treatment in extremely preterm infants improves upon adjustment of the baseline characteristics 2023 ·Pediatric Research ·Olivier Baud, Philippe Lehert, (unknown)	8
3	Bioavailability and cardiovascular effects of adrenaline administered by Anapen 500 μg auto‐injector in healthy volunteers 2022 ·British Journal of Clinical Pharmacology ·Thierry Duvauchelle, Philippe Robert, Yves Donazzolo, (unknown), (unknown), Philippe Lehert, Jeanne‐Marie Lecomte, Jean‐Charles Schwartz	5
4	Long‐term treatment with metformin in type 2 diabetes and vitamin D levels: A post‐hoc analysis of a randomized placebo‐controlled trial 2018 ·Diabetes Obesity and Metabolism ·Mattijs Out, (unknown), Philippe Lehert, Casper G. Schalkwijk, Coen D.A. Stehouwer, Adriaan Kooy	11
5	Bioavailability and Cardiovascular Effects of Adrenaline Administered by Anapen Autoinjector in Healthy Volunteers 2017 ·The Journal of Allergy and Clinical Immunology In Practice ·Thierry Duvauchelle, Philippe Robert, Yves Donazzolo, (unknown), (unknown), Philippe Lehert, Jeanne‐Marie Lecomte, Jean‐Charles Schwartz	31
6	Prevention of Dysbiosis Complications with Autologous Fecal Microbiota Transplantation (auto-FMT) in Acute Myeloid Leukemia (AML) Patients Undergoing Intensive Treatment (ODYSSEE study): First Results of a Prospective Multicenter Trial 2017 ·Blood ·Mohamad Mohty, Florent Malard, Evelyne D’Incan, Xavier Thomas, Christian Récher, Anne‐Sophie Michallet, Pierre Péterlin, Anne Vekhoff, Norbert Vey, (unknown), Philippe Lehert, Joël Doré, Ollivier Legrand	5
7	Measuring Sleep Disturbances in Patients With Alcohol Use Disorders 2015 ·Journal of Addiction Medicine ·Pascal Perney, (unknown), Barbara J. Mason, Maurice Demattéis, Philippe Lehert	12
8	Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis 2015 ·Climacteric ·Philippe Lehert, Paulina Villaseca, Eef Hogervorst, Pauline M. Maki, Victor W. Henderson	74
9	A meta-analysis of randomized double-blind clinical trials in CMT1A to assess the change from baseline in CMTNS and ONLS scales after one year of treatment 2015 ·Orphanet Journal of Rare Diseases ·Jonas Mandel, Viviane Bertrand, Philippe Lehert, Shahram Attarian, Laurent Magy, Joëlle Micallef, Ilya Chumakov, Catherine Scart‐Grès, Mickaël Guedj, Daniel Cohen	15
10	Adding luteinizing hormone to follicle stimulating hormone during ovarian stimulation increases pregnancy rate in IVF for poor ovarian responders 2012 ·Fertility and Sterility ·C Rongières, (unknown), Catherine Célébi, (unknown), (unknown), Philippe Lehert	2
11	Epidemiology of premenstrual symptoms and disorders 2012 ·Menopause international ·Lorraine Dennerstein, Philippe Lehert, Klaas Heinemann	70
12	Global epidemiological study of variation of premenstrual symptoms with age and sociodemographic factors 2011 ·Menopause international ·Lorraine Dennerstein, Philippe Lehert, Klaas Heinemann	23
13	Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial breakdown → 2010 ·BMJ ·J. de Jager, Adriaan Kooy, Philippe Lehert, M. G. Wulffelé, J. van der Kolk, D. Bets, J. Verbürg, A. J. M. Donker, Coen D.A. Stehouwer	463
14	A population-based survey of Asian women's experience of premenstrual symptoms 2010 ·Menopause international ·Lorraine Dennerstein, Philippe Lehert, (unknown), (unknown), DooSeok Choi	16
15	Meerwaarde van toevoeging metformine aan insulinetherapie bij type 2-diabetes. Gunstiger gewicht met minder macrovasculaire complicaties 2009 ·Nederlandsch tijdschrift voor geneeskunde/Nederlands tijdschrift voor geneeskunde/NTvG-databank ·Adriaan Kooy, J. de Jager, Philippe Lehert, D. Bets, M. G. Wulffelé, (unknown), Coen D.A. Stehouwer	1
16	Premenstrual symptoms – severity, duration and typology: an international cross-sectional study 2009 ·Menopause international ·Lorraine Dennerstein, Philippe Lehert, Torbjörn Bäckström, Klaas Heinemann	53
17	The menopausal transition: a 9-year prospective population-based study. The Melbourne Women's Midlife Health Project 2004 ·Climacteric ·(unknown), Lorraine Dennerstein, (unknown), Philippe Lehert, Henry Burger	212
18	Parkinson's disease home diary: Further validation and implications for clinical trials 2004 ·Movement Disorders ·Robert A. Hauser, F. Deckers, Philippe Lehert	144
19	Improvement in Quality of Life After Treatment for Alcohol Dependence With Acamprosate and Psychosocial Support 2004 ·Alcoholism Clinical and Experimental Research ·Marsha Y. Morgan, F. Landron, Philippe Lehert, (unknown)	75
20	The European NEAT program: an integrated approach using acamprosate and psychosocial support for the prevention of relapse in alcohol-dependent patients with a statistical modeling of therapy success prediction. 2002 ·PubMed ·Isidore Pelc, (unknown), Philippe Lehert, Felix Fischer, (unknown), F. Landron, (unknown), Marsha Y. Morgan	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact